Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Neoplasms 1

Interventions

Fluorouracil 10 Oxaliplatin 8 Capecitabine 7 Specimen Handling 6 Nivolumab 6 Leucovorin 6 trastuzumab deruxtecan 5 Magnetic Resonance Spectroscopy 5 pembrolizumab 4 fludarabine 4 Paclitaxel 4 Docetaxel 4 Cyclophosphamide 4 Cisplatin 4 Biopsy 4 aldesleukin 3 Trastuzumab 3 zimberelimab 2 ulixertinib 2 fludarabine phosphate 2 Ramucirumab 2 Irinotecan 2 Folfox protocol 2 zolbetuximab 1 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 trametinib 1 toripalimab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Anastomosis, Roux-en-Y × 30 days × Clear all

NCT06768164 2026-05-20

BYQoL-GC

Assistance Publique - Hôpitaux de Paris

Phase 3 Recruiting

Gastrointestinal

Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡